Skip to content

Clinical trials

Withdrawn Phase 1/2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eastern Cooperative Oncology Group1
NKGen Biotech, Inc.1
National Cancer Institute (NCI)1
Weill Medical College of Cornell University1
Zhejiang Provincial People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms5
Neoplasms2
Stomach Neoplasms2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Endometrial Neoplasms1
Gastrointestinal Neoplasms1
Neoplasm Metastasis1
Ovarian Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.